Skip to main navigation

Back to SpringWorksTx.com
Investors & Media
Contact Us
Linkedin
Twitter

Overview
News & Events
- Press Releases
- Events & Presentations
Corporate Governance
Financial Information
- SEC Filings
- Annual Reports
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Investor Resources
Investors + Media
Medical Professionals
Contact Us
Linkedin
Twitter

Press Releases

Items Per Page

Year

06 May 2021

SpringWorks Therapeutics Expands Targeted Oncology Pipeline with Exclusive Worldwide License to TEAD Inhibitor Portfolio

PDF Version

12 Apr 2021

Allogene Therapeutics and SpringWorks Therapeutics Announce Dosing of First Patient in Phase 1 Study Evaluating ALLO-715 in Combination with Nirogacestat in Patients with Relapsed or Refractory Multiple Myeloma

PDF Version

01 Apr 2021

SpringWorks Therapeutics Announces Dosing of First Patient in Phase 1b Combination Study Evaluating Nirogacestat and Janssen’s BCMA Bispecific Antibody Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma

PDF Version

22 Mar 2021

SpringWorks Therapeutics Appoints Bhavesh Ashar as Chief Commercial Officer

PDF Version

25 Feb 2021

SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights

PDF Version

25 Feb 2021

SpringWorks Therapeutics Reports Interim Data from Phase 2b ReNeu Trial of Mirdametinib for Patients with NF1-PN and Provides Trial Update

PDF Version

22 Feb 2021

SpringWorks Therapeutics to Present at Upcoming Investor Conferences

PDF Version

04 Feb 2021

SpringWorks Therapeutics to Present at the Guggenheim Healthcare Talks 2021 Oncology Day

PDF Version

05 Jan 2021

SpringWorks Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

PDF Version

15 Dec 2020

SpringWorks Therapeutics Announces Executive Leadership Promotions

PDF Version

Pagination

First page
Previous page
…
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Page 9
Page 10
Page 11
…
Next page
Last page

Displaying 61 - 70 of 121

Springworks - Toolkits

Print Page
Email Alerts
RSS Feeds
Investor Contacts

Request E-mail Alerts

Social Links

Footer 1

Who We Are
Focus Areas

Footer 2

Pipeline
Careers
- View Opportunities
- Desmoid Tumor Commercial Team

Footer 3

Patients
Contact

Footer 4

Investors & Media

© 2023 SpringWorks Therapeutics. All rights reserved.

Copyright Links

Privacy Policy
Terms of Use
Cookie Policy